Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18642,146,0.93 [0.80-1.07],0.2931246671925506
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19603,203,0.97 [0.86-1.10],0.6534956429532135
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19376,1411,1.01 [0.96-1.05],0.7834264111935004
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,19617,444,1.01 [0.93-1.09],0.8673836749102057
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18969,3450,1.00 [0.97-1.03],0.8592874750088078
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18951,3505,0.98 [0.96-1.01],0.2945793872704619
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19372,1159,0.99 [0.95-1.05],0.8301589406161066
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19530,107,0.91 [0.77-1.07],0.2498121250756075
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17304,1025,0.96 [0.91-1.01],0.1352765140333409
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16669,1234,0.96 [0.92-1.01],0.1139752597594955
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16332,268,0.98 [0.88-1.09],0.7439783991217523
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12770,2215,0.96 [0.93-1.00],0.0392640224287754
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16279,392,1.04 [0.95-1.13],0.4409412780035511
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19585,1372,0.99 [0.95-1.04],0.6974444420385546
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Mycoses,19687,514,1.01 [0.93-1.09],0.8593919462491512
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18962,997,0.99 [0.94-1.05],0.7240021406312946
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19629,1133,0.95 [0.91-1.00],0.075452929182357
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18416,203,0.97 [0.86-1.10],0.6741598312967729
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19738,51,1.07 [0.84-1.36],0.5979317535750351
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19485,989,0.96 [0.91-1.01],0.1351372195621761
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19488,65,1.07 [0.86-1.33],0.546608164613165
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19683,112,1.08 [0.91-1.27],0.3671047673469971
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19668,97,1.09 [0.91-1.30],0.3315473468472642
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18352,387,1.03 [0.95-1.13],0.4641972985684361
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18216,251,1.02 [0.91-1.14],0.7350458444176626
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18315,102,1.11 [0.94-1.33],0.2215634091791976
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19723,47,0.86 [0.67-1.10],0.2195234805273335
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19677,146,1.07 [0.93-1.24],0.3459514592734073
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral warts,19579,48,1.46 [1.13-1.89],0.0040557831899725
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19602,71,0.97 [0.79-1.19],0.7798883687526929
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm,19498,221,0.93 [0.83-1.04],0.2020363960459034
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19667,38,0.92 [0.70-1.22],0.579127815168353
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19650,38,1.05 [0.79-1.39],0.733461114602195
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9326,67,0.91 [0.74-1.12],0.3792401835014395
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19349,1413,0.99 [0.95-1.04],0.82169877773777
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of meninges,19725,57,1.00 [0.79-1.26],0.996627164041299
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19658,71,1.04 [0.84-1.27],0.7366805276379927
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19716,101,0.97 [0.82-1.15],0.7244305620311726
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of ovary,10362,65,0.97 [0.78-1.20],0.7870321472266517
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19703,380,0.97 [0.89-1.06],0.5672745618928428
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Caecum,19715,326,0.98 [0.90-1.08],0.7546802839724809
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19612,76,0.88 [0.72-1.07],0.1943132345088139
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,19702,218,1.02 [0.91-1.15],0.7587943118099073
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Rectum,19659,341,0.95 [0.87-1.05],0.3251281594433531
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19609,594,1.01 [0.94-1.09],0.7337542228968668
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19694,449,1.01 [0.93-1.10],0.7552321689506423
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Carcinoma in situ of breast,7807,44,0.92 [0.71-1.20],0.55195108463826
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7840,54,1.07 [0.84-1.37],0.5599681401693852
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14149,63,0.87 [0.71-1.08],0.2191568981912141
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14169,83,0.90 [0.75-1.09],0.2792978402247948
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19687,109,0.88 [0.74-1.03],0.1133957153367778
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma, any site",19688,106,0.88 [0.74-1.04],0.1278546413100214
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Leiomyoma of uterus,10128,146,0.98 [0.85-1.13],0.7677532757379586
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lung cancer and mesothelioma,12580,421,0.95 [0.87-1.03],0.1967018416087566
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lymphoid leukaemia,14149,63,0.87 [0.70-1.07],0.1879405760534424
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14272,186,1.10 [0.96-1.25],0.1568350437088943
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14339,253,0.96 [0.86-1.07],0.4468332650641291
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7921,97,0.88 [0.74-1.05],0.1543081631703592
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14181,95,1.05 [0.87-1.25],0.6237236789107488
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14210,124,1.12 [0.95-1.31],0.1741669027357809
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14197,111,0.90 [0.76-1.05],0.178900475164263
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7902,78,0.89 [0.74-1.09],0.2606047345355171
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14194,108,0.93 [0.79-1.10],0.3847686793855853
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7068,806,0.93 [0.87-0.98],0.0116945983328141
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14197,111,0.88 [0.75-1.03],0.1213752222601658
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14167,81,1.02 [0.84-1.23],0.8587787667262662
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14204,118,1.04 [0.88-1.22],0.6575317181748566
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi,19612,159,1.09 [0.95-1.25],0.231260333762015
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi of trunk,19715,66,1.26 [1.02-1.57],0.0352687244462061
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanoma in situ,14132,98,1.05 [0.88-1.26],0.5592933587869795
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14190,104,0.91 [0.77-1.08],0.2860291241083897
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14257,171,0.94 [0.82-1.07],0.3568467632246017
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14380,294,0.86 [0.78-0.95],0.0029872650434748
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14197,111,0.99 [0.84-1.17],0.9124762920921514
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Other benign neoplasms of skin,19595,143,0.97 [0.84-1.12],0.6944840544848007
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15330,1244,0.97 [0.92-1.02],0.1819223283471207
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15396,1310,0.98 [0.93-1.02],0.3089530726043715
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19483,319,0.93 [0.84-1.02],0.1301680819957432
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17834,105,0.99 [0.84-1.17],0.9185028221222926
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19223,59,1.10 [0.87-1.38],0.4254087268216999
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19124,2881,1.01 [0.97-1.04],0.748151227113417
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18330,60,1.43 [1.14-1.80],0.002265808539722
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19352,60,0.92 [0.73-1.14],0.4334971714360144
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19337,1608,1.00 [0.96-1.04],0.9335745452806934
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19335,1606,1.00 [0.96-1.04],0.8945408863942725
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17822,93,0.86 [0.72-1.02],0.0837839090123512
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19438,1168,1.10 [1.04-1.16],0.0003609250199381
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19390,98,0.95 [0.79-1.13],0.5344384220150515
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19223,59,0.86 [0.69-1.07],0.1784305395841467
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19231,67,1.02 [0.83-1.26],0.8544631266955042
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19586,294,0.80 [0.72-0.88],7.309731784831634e-06
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19632,32,0.92 [0.68-1.25],0.595867362439586
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19530,238,0.71 [0.64-0.79],8.423966789876078e-10
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18380,110,1.08 [0.91-1.27],0.3937103568538177
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13397,329,0.97 [0.88-1.06],0.4749146129710906
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18476,85,1.05 [0.87-1.28],0.6069745563558488
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18481,90,1.12 [0.93-1.34],0.2396359846381357
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13130,62,0.97 [0.78-1.21],0.7866062627522235
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18390,42,0.91 [0.70-1.18],0.4720258866311793
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17768,266,0.92 [0.83-1.02],0.1292111406914224
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19097,747,0.93 [0.87-0.99],0.0250955751046904
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18757,407,0.95 [0.87-1.03],0.2162282233580293
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18495,145,1.02 [0.88-1.18],0.7984611551572283
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19515,1167,1.06 [1.01-1.11],0.0289890140453394
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16709,1137,1.06 [1.01-1.12],0.0297415904409547
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13132,64,0.90 [0.73-1.12],0.3459017497388178
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17829,84,1.06 [0.87-1.28],0.5745181981243459
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13368,300,0.96 [0.87-1.06],0.4604723640900796
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13115,47,1.03 [0.80-1.33],0.8242587249774622
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16886,3818,1.02 [0.99-1.05],0.112537861863089
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13292,224,0.91 [0.81-1.02],0.1211350417699495
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13650,582,0.97 [0.90-1.04],0.3716942410799251
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19692,302,0.99 [0.90-1.10],0.9131992721727789
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19512,122,0.87 [0.75-1.02],0.085502072227566
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13189,121,0.93 [0.80-1.09],0.3961343323920773
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13136,68,0.96 [0.78-1.19],0.7284462739835991
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19198,1453,0.99 [0.95-1.04],0.7635287255482643
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13380,312,0.97 [0.88-1.07],0.5898890469781493
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13389,321,0.91 [0.83-1.00],0.0626593737259678
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13781,713,1.05 [0.98-1.12],0.1427561480902631
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13195,127,0.91 [0.78-1.06],0.2068973964028825
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19507,117,0.87 [0.74-1.02],0.0766268572354371
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13817,749,1.00 [0.94-1.06],0.9351722673993872
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13600,532,0.97 [0.90-1.05],0.4648466225623431
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17560,58,1.03 [0.82-1.29],0.8067198444930321
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18427,5359,1.00 [0.98-1.03],0.6843034709341349
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17793,48,0.97 [0.76-1.25],0.8394172985572228
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17791,46,0.95 [0.74-1.23],0.6985420444960142
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19594,1554,0.98 [0.93-1.02],0.301272906197578
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19592,1552,0.98 [0.94-1.02],0.3525573477427706
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17800,55,0.98 [0.77-1.23],0.845309697006123
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19436,957,1.02 [0.97-1.08],0.4577089841513069
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14898,1830,0.98 [0.94-1.02],0.248371069933089
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19727,241,0.92 [0.83-1.03],0.1558198196748447
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18442,92,0.96 [0.81-1.15],0.6856646487306091
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18577,98,0.97 [0.82-1.16],0.7570328612806129
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18623,144,1.18 [1.01-1.36],0.0330803155977372
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13233,165,0.99 [0.87-1.14],0.9353727491106716
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17388,156,0.97 [0.85-1.12],0.6882322004653211
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2109,80,0.96 [0.78-1.17],0.6654737517981233
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2242,246,0.95 [0.85-1.06],0.3480732745876073
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17300,68,1.04 [0.84-1.29],0.7166835237626537
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2075,47,0.81 [0.63-1.05],0.1106625098314482
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19045,1813,1.01 [0.97-1.05],0.6526038725414931
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18853,503,0.90 [0.84-0.97],0.0075598997687687
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17871,369,1.00 [0.91-1.09],0.9247694377942248
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13953,885,0.97 [0.92-1.03],0.3641898595431011
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19621,261,0.85 [0.77-0.95],0.0027361705731331
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18507,229,0.90 [0.81-1.00],0.0596334743243602
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Angina pectoris,17119,1284,0.98 [0.93-1.03],0.4201580053709183
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18592,314,0.89 [0.81-0.98],0.0147466958505704
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18345,67,1.02 [0.83-1.25],0.8596785337048727
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18508,230,1.01 [0.90-1.13],0.8563764501867565
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10089,2370,0.95 [0.91-0.98],0.0022551875699246
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,AV-block,15107,555,0.96 [0.90-1.04],0.330046868187629
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19668,467,0.97 [0.90-1.05],0.4579918591391714
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,7940,221,1.02 [0.91-1.14],0.7451396493751898
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14722,170,0.82 [0.72-0.94],0.0028831470263867
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14640,88,0.96 [0.80-1.16],0.6854946112789414
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19732,61,1.07 [0.85-1.33],0.5754748343789882
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Conduction disorders,15839,1287,0.97 [0.92-1.01],0.1634219482639851
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18121,2308,0.98 [0.94-1.01],0.2407109680937463
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16002,7596,0.99 [0.97-1.01],0.4429700971204477
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18411,287,0.88 [0.79-0.97],0.0100094402772775
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Endocarditis,14628,76,0.97 [0.80-1.19],0.7889840580867271
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19496,1373,0.99 [0.95-1.04],0.7128073261223684
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertension,17043,6706,1.00 [0.98-1.03],0.7343322682154898
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17047,6710,1.00 [0.98-1.02],0.7606839271317111
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19595,86,0.80 [0.67-0.96],0.0143026450408678
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10576,239,1.02 [0.92-1.15],0.6740241254109487
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10464,127,1.02 [0.88-1.19],0.7700525830531427
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypotension,19587,1314,0.99 [0.95-1.04],0.7217280321345978
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18667,123,0.86 [0.74-1.00],0.0565223749538837
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18269,2434,0.99 [0.95-1.02],0.4164392115208025
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19315,664,1.03 [0.96-1.10],0.4151607015926817
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14977,425,0.95 [0.88-1.04],0.2736085226417185
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19185,894,1.01 [0.95-1.07],0.7801629615703589
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16602,767,1.03 [0.96-1.09],0.4274555382433842
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19624,164,1.14 [0.99-1.30],0.0663378678717329
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19700,338,0.99 [0.90-1.09],0.8298502998058022
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,18182,58,0.86 [0.69-1.08],0.1864054502619966
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other aneurysm,18366,88,1.07 [0.89-1.28],0.4932018401401294
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,15045,493,1.00 [0.92-1.08],0.9148189225946008
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18387,109,1.02 [0.87-1.21],0.7755304099139718
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18546,268,0.96 [0.86-1.06],0.4328446514418409
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14743,191,1.00 [0.88-1.13],0.9794061357652836
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,18213,89,1.04 [0.86-1.25],0.6738228070301256
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18163,39,1.05 [0.79-1.38],0.7407874482483944
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18055,71,1.01 [0.82-1.25],0.8963546135953485
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18264,140,1.04 [0.90-1.21],0.6145069518812696
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15737,1185,0.95 [0.91-1.00],0.0522393194069886
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18323,50,0.94 [0.74-1.20],0.6244647988955796
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18881,603,0.97 [0.90-1.04],0.3246488051509829
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19091,461,0.97 [0.90-1.05],0.4919371180032383
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18780,796,0.98 [0.92-1.04],0.521219416363432
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8063,344,0.94 [0.85-1.03],0.1617307342058406
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18734,489,0.99 [0.91-1.06],0.7150111347578234
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18483,359,0.88 [0.80-0.96],0.0039613095338932
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19124,494,0.94 [0.87-1.02],0.1509823300920049
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19653,802,0.95 [0.89-1.01],0.0826899113738287
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14983,431,0.96 [0.89-1.05],0.3684490325374431
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19086,456,0.97 [0.90-1.05],0.4975305212098572
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18193,209,0.96 [0.86-1.09],0.5399222832367437
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19299,755,1.01 [0.95-1.08],0.6861456133678041
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19288,787,1.01 [0.95-1.08],0.6445903985288286
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18642,50,0.95 [0.75-1.21],0.7070020196942737
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18358,80,0.88 [0.73-1.07],0.1997041341872281
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18916,265,1.09 [0.98-1.21],0.1175562241852345
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18570,279,1.00 [0.90-1.11],0.9880613532752772
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Varicose veins,18557,433,1.02 [0.94-1.11],0.6273034104697292
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18293,97,0.85 [0.72-1.01],0.0629449539998523
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19496,783,0.92 [0.87-0.98],0.0085185024465024
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19669,279,1.07 [0.96-1.18],0.2083039783102148
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16975,1168,1.03 [0.98-1.09],0.187669289849376
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Any mental disorder,19300,3493,1.02 [0.99-1.05],0.2376959032320418
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19644,328,1.03 [0.94-1.14],0.4859788933301587
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16992,1185,1.06 [1.01-1.12],0.0255324811665987
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15872,65,1.13 [0.91-1.40],0.2703609387129236
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Smoking dependency,19305,979,1.04 [0.98-1.09],0.2023721127906817
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17016,1209,1.03 [0.98-1.08],0.2672567076411501
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Vascular dementia,19031,192,0.92 [0.81-1.04],0.1717247609237855
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Alzheimer disease,19735,502,0.96 [0.89-1.04],0.2831468400214177
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12316,95,1.01 [0.84-1.21],0.9184554791778052
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Bell's palsy,18196,71,0.98 [0.80-1.21],0.858298291922134
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18548,423,1.07 [0.98-1.17],0.111631568726024
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral cysts,19368,202,1.00 [0.89-1.13],0.9407792778891906
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19675,326,0.92 [0.83-1.01],0.0728468710513291
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19040,72,1.01 [0.83-1.24],0.8865881510201279
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19720,61,0.84 [0.68-1.04],0.1108242932271108
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19234,68,1.05 [0.85-1.30],0.6326403493349713
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Epilepsy,18493,246,0.96 [0.86-1.07],0.4426055750324721
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19353,1106,1.01 [0.96-1.06],0.7357244144207722
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19686,531,0.94 [0.87-1.01],0.0951090776385168
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19184,2814,0.95 [0.92-0.98],0.0020105425569548
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,19427,43,1.37 [1.04-1.80],0.0238048882840112
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hemiplegia,19614,265,0.96 [0.87-1.07],0.4851162877489346
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hydrocephalus,19226,60,0.94 [0.75-1.17],0.5509864431040417
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19724,56,1.03 [0.82-1.30],0.7977827181857412
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18186,61,0.87 [0.70-1.08],0.1958868096467982
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18186,61,0.92 [0.74-1.15],0.4644503572348528
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Memory loss,18820,133,0.98 [0.84-1.14],0.7743230767218241
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Migraine,18480,233,1.02 [0.91-1.14],0.7371752709451105
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19693,212,1.02 [0.91-1.15],0.7306636187060677
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Motor neuron disease,12409,166,1.01 [0.88-1.15],0.9032760576391876
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19631,52,1.03 [0.81-1.30],0.8159786402723523
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19147,1022,1.02 [0.96-1.07],0.5516769077467962
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Neurological diseases,18502,3505,0.99 [0.96-1.02],0.4734788821720317
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19210,242,0.96 [0.86-1.07],0.4151657205458111
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18461,336,1.03 [0.94-1.14],0.4937275418225735
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19671,290,1.01 [0.91-1.12],0.8220631988486392
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14990,806,0.97 [0.91-1.03],0.3106594435515744
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19233,67,0.90 [0.73-1.11],0.3138472366548751
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19298,132,0.90 [0.78-1.05],0.1689344390026773
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19332,177,0.98 [0.86-1.11],0.7045885983110011
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18203,78,0.99 [0.81-1.20],0.9186917542798332
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other headache syndromes,18293,46,1.04 [0.81-1.35],0.7536833522513604
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other neurological diseases,19642,476,0.98 [0.91-1.06],0.6752397439403931
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other sleep disorders,18662,415,0.98 [0.90-1.07],0.6230435884019081
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Parkinson's disease,19704,333,0.91 [0.83-1.00],0.0515332427212464
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19206,40,1.09 [0.83-1.45],0.5266229528505704
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,19734,77,0.90 [0.74-1.10],0.3078017952346302
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Sleep apnoea,19553,359,0.97 [0.89-1.07],0.5488399052522214
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19432,51,1.05 [0.82-1.34],0.7070465814908602
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19723,185,0.99 [0.88-1.13],0.937852776035393
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18184,59,1.03 [0.82-1.29],0.7967270342877135
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19735,507,0.96 [0.89-1.03],0.2717853337744357
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18975,186,0.91 [0.81-1.04],0.1579089104139973
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19206,124,0.98 [0.84-1.14],0.7832629048519016
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19363,470,0.96 [0.88-1.04],0.289565987775142
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19540,217,0.91 [0.81-1.02],0.0943650513989545
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18683,59,1.07 [0.85-1.34],0.5837673120393985
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18658,34,1.44 [1.06-1.97],0.021157441155429
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19632,63,1.15 [0.92-1.44],0.2067644078133988
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19466,186,0.98 [0.86-1.11],0.7206257364168926
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2079,50,0.80 [0.62-1.02],0.0705904200421975
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2545,92,0.95 [0.79-1.15],0.6028039473042645
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19172,90,1.11 [0.92-1.33],0.2722717067195644
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19501,1201,1.02 [0.97-1.08],0.3498087586040171
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19378,754,1.01 [0.95-1.07],0.8268628195186064
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18878,254,1.07 [0.96-1.19],0.2514757312504154
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19678,785,0.97 [0.91-1.03],0.367828814989092
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19730,67,1.25 [1.00-1.55],0.0458125519550353
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19626,733,0.97 [0.91-1.04],0.3724182386481006
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19700,420,1.00 [0.92-1.09],0.9633191449198948
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19631,195,1.02 [0.90-1.16],0.7167554474573472
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18714,90,1.15 [0.95-1.38],0.1547374827129892
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18714,90,0.96 [0.80-1.15],0.6752020298405849
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18689,65,1.11 [0.89-1.39],0.3341026945388854
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19619,855,0.98 [0.92-1.04],0.4615398887573066
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18997,233,0.97 [0.86-1.08],0.548023027871445
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18951,58,0.78 [0.63-0.98],0.0289636395467671
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19390,110,0.97 [0.83-1.15],0.7475370812971396
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19602,322,0.99 [0.90-1.09],0.7865695364496651
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19078,185,1.01 [0.89-1.15],0.8237920004921295
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19556,120,1.00 [0.85-1.17],0.9947369952572994
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19320,556,0.98 [0.91-1.06],0.6456363607937337
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19218,136,0.96 [0.83-1.12],0.6207778590516642
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17674,2749,1.00 [0.97-1.04],0.9266500839580464
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19565,285,0.97 [0.88-1.08],0.6105455421838802
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19721,157,1.02 [0.89-1.17],0.8148171776474723
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19094,470,0.99 [0.92-1.07],0.8385538859534805
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19362,82,0.98 [0.81-1.19],0.8363383592668279
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19722,59,1.27 [1.01-1.60],0.0409322292263737
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18731,107,0.88 [0.75-1.04],0.1441923787665618
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18778,154,0.85 [0.74-0.97],0.018993963273008
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18442,142,1.11 [0.96-1.28],0.1640956267120875
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18938,45,0.79 [0.62-1.02],0.0704629252536748
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18365,65,0.86 [0.70-1.06],0.1492605514389981
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18864,100,0.88 [0.74-1.04],0.1285686704986001
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19009,245,1.02 [0.92-1.14],0.6780742905309769
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18758,134,1.04 [0.90-1.21],0.5761029973766363
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18381,81,1.18 [0.97-1.44],0.0910517605014522
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18405,105,1.02 [0.86-1.21],0.7808664709318658
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17203,2278,0.99 [0.96-1.03],0.6904139490941441
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18706,82,1.12 [0.92-1.36],0.2548512802907289
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19501,419,1.02 [0.94-1.12],0.5697587517219223
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19150,68,1.08 [0.88-1.34],0.4472370236059344
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19241,159,1.02 [0.89-1.17],0.7930409060409715
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19538,97,0.85 [0.72-1.02],0.0736093444334031
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19698,118,1.05 [0.90-1.23],0.5459800090616396
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19623,95,1.14 [0.95-1.36],0.1542890505465113
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19499,58,1.05 [0.83-1.32],0.7002809397567998
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19499,58,1.01 [0.80-1.26],0.9573709472990096
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19641,1010,1.02 [0.97-1.08],0.3906647222430969
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19400,769,1.03 [0.97-1.10],0.2979108227079514
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18755,124,0.88 [0.76-1.03],0.1110957323523288
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18708,77,1.20 [0.98-1.47],0.0728959755063732
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,19568,51,1.01 [0.79-1.29],0.9485258571959524
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19668,151,0.97 [0.84-1.12],0.6762760422931795
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19567,50,0.92 [0.72-1.17],0.4989362019985617
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza,17515,129,1.05 [0.90-1.22],0.5638764725522534
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17512,126,1.07 [0.92-1.25],0.3928927803488264
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12244,85,1.18 [0.97-1.43],0.092178310245882
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,19649,197,1.01 [0.89-1.14],0.9166175516733328
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13324,1483,1.05 [1.01-1.10],0.0274480813433362
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13624,1465,1.05 [1.00-1.10],0.0449823876922781
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19297,151,1.04 [0.90-1.20],0.5941234427326283
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17472,86,1.07 [0.89-1.29],0.4571737475609363
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bronchiectasis,16529,436,1.08 [0.99-1.17],0.0816149539321604
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16155,62,1.26 [1.01-1.57],0.0443711763809748
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18779,2686,1.03 [1.00-1.07],0.0452482156612751
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18695,63,0.97 [0.78-1.20],0.7591226386799249
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,18744,112,0.95 [0.81-1.12],0.5369315444090399
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19486,1362,1.00 [0.96-1.05],0.9402156072391602
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,18702,70,1.01 [0.82-1.24],0.9402328404887176
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17903,5135,1.01 [0.99-1.04],0.3445469294930141
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18926,294,1.00 [0.91-1.11],0.9572681126591784
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Early onset COPD,18223,99,0.94 [0.80-1.12],0.5105235352354425
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Emphysema,16466,373,1.02 [0.93-1.11],0.671656086456591
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18607,406,1.00 [0.92-1.09],0.9499068662008112
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19511,2125,1.00 [0.96-1.03],0.8467896369284014
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,18642,441,1.01 [0.93-1.10],0.7521528118157457
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Later onset COPD,19275,1263,1.01 [0.96-1.06],0.7811046506568332
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19719,382,1.03 [0.94-1.12],0.522611323338467
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Nasal polyp,18718,86,0.92 [0.77-1.11],0.3919893285046566
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19491,1069,0.99 [0.94-1.04],0.5982351559370422
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,19491,2251,1.00 [0.97-1.04],0.9593466624089652
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19270,638,1.00 [0.93-1.07],0.8870374661032765
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other pleural conditions,17293,53,0.79 [0.63-0.99],0.0438067228804007
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19619,515,1.01 [0.94-1.09],0.7848335289931878
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19625,1449,1.02 [0.97-1.07],0.439133987037539
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural effusion,18359,1119,0.98 [0.94-1.04],0.5588798275491109
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural plaque,17457,217,0.98 [0.88-1.11],0.7852392167594795
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19270,1884,0.99 [0.95-1.03],0.6757583803070573
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19623,286,1.03 [0.93-1.14],0.5837292469005002
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumothorax,17392,152,0.86 [0.75-0.99],0.0345320828190397
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pollen allergy,19726,165,1.05 [0.91-1.20],0.5138770474375032
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,19177,73,0.87 [0.72-1.06],0.1784626258811912
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12220,61,1.27 [1.02-1.59],0.0352538942478623
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19476,1054,0.98 [0.93-1.04],0.5492414684503875
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18830,198,1.01 [0.89-1.14],0.8750858498311263
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Viral pneumonia,17629,243,1.01 [0.90-1.12],0.9255245589695236
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19308,194,0.97 [0.86-1.10],0.6483044206956677
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6370,101,1.05 [0.88-1.25],0.6171315393218293
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12627,52,0.97 [0.76-1.23],0.7960528006989606
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute appendicitis,19633,108,0.94 [0.80-1.11],0.4604647571981162
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute gastritis,13814,85,1.07 [0.89-1.29],0.4730916058839352
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,18032,166,1.03 [0.90-1.18],0.6699200578058058
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute peritonitis,19333,91,1.04 [0.87-1.25],0.6643131527974113
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18911,50,0.75 [0.60-0.95],0.01747141922317
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,14156,427,0.99 [0.91-1.08],0.8934870796834955
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17988,122,1.05 [0.90-1.23],0.5330377247936726
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19382,122,1.05 [0.90-1.23],0.5429517037826647
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholecystitis,18049,183,0.90 [0.80-1.03],0.1178565956354725
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholelithiasis,18750,884,0.99 [0.94-1.05],0.8118240960396743
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic gastritis,14019,290,0.98 [0.89-1.09],0.749603399767993
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17912,46,0.87 [0.68-1.12],0.285385086882959
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19619,110,0.86 [0.73-1.01],0.0603555312506578
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Coeliac disease,18287,101,1.02 [0.86-1.21],0.8442909951841631
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Collagenous colitis,18242,86,0.92 [0.77-1.11],0.3917876332680917
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19636,141,0.95 [0.82-1.09],0.453048703485043
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Constipation,19497,1741,0.98 [0.94-1.02],0.390947905615399
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn disease,18224,68,1.10 [0.89-1.36],0.3869922727522252
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19435,52,1.04 [0.82-1.32],0.7595129573330341
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18219,63,1.12 [0.90-1.39],0.3271502839511956
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Dental caries,19208,155,0.94 [0.82-1.08],0.3682918689850615
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17090,2158,0.99 [0.95-1.03],0.6097620550414735
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of appendix,19657,132,0.94 [0.81-1.09],0.4247104291559996
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of liver,19633,772,0.95 [0.89-1.01],0.1174555541739886
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17587,3858,1.00 [0.97-1.03],0.8896011137968949
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19449,396,0.96 [0.88-1.05],0.4017156408993565
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19666,424,0.99 [0.91-1.08],0.8732776653616104
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19128,75,0.90 [0.74-1.10],0.3051979884440111
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19026,47,0.97 [0.76-1.25],0.8226828982514865
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19463,1277,0.96 [0.92-1.01],0.1039288409053689
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of tongue,19034,77,1.05 [0.86-1.28],0.6325087377045155
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19147,1281,0.99 [0.95-1.04],0.8327779624500038
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15775,3200,0.98 [0.95-1.01],0.1386497076310963
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,13933,204,0.99 [0.88-1.12],0.9235713495974746
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19650,164,1.04 [0.90-1.19],0.6183071462575025
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19710,18,1.06 [0.70-1.60],0.7852681698545934
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18989,128,0.87 [0.75-1.01],0.0597726363541582
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12667,92,1.03 [0.86-1.23],0.7609562492168788
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,14212,483,1.03 [0.95-1.11],0.5144693871977668
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastric ulcer,14080,351,0.99 [0.91-1.09],0.8785312250460309
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15963,2234,0.99 [0.96-1.03],0.743146291183517
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14266,537,0.98 [0.91-1.06],0.6508362505637784
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14327,6965,0.99 [0.97-1.01],0.5510061061125262
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,GI-bleeding,19239,1053,0.95 [0.90-1.00],0.0588777474579702
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19097,44,0.92 [0.71-1.19],0.5148697400750841
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13410,998,0.95 [0.90-1.00],0.0534306687228565
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18919,58,0.78 [0.63-0.97],0.0235600698076547
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Hernia,17999,3067,1.00 [0.97-1.03],0.9813185861578966
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impacted teeth,19711,17,1.10 [0.72-1.68],0.6583883427516715
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impaction of intestines,12639,64,0.91 [0.74-1.13],0.4105411454821521
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Inguinal hernia,15860,928,0.99 [0.94-1.05],0.8456965643860122
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15030,98,1.00 [0.84-1.19],0.992633540868866
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12670,95,0.89 [0.74-1.06],0.1848511855118449
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18306,120,0.97 [0.83-1.14],0.7397009192386894
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13003,428,0.99 [0.91-1.07],0.7661990946929158
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19711,275,1.03 [0.93-1.15],0.5602221395114574
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18821,665,1.02 [0.96-1.09],0.5020779298518543
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19085,929,1.00 [0.94-1.05],0.8904063533625831
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13915,186,0.84 [0.75-0.95],0.0070226659957967
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophagitis,14326,597,1.02 [0.95-1.10],0.5393077051316553
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19686,113,1.06 [0.90-1.25],0.4972661236974245
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15000,68,1.08 [0.87-1.33],0.4955051615225587
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13734,1159,1.01 [0.96-1.06],0.7542130537699678
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18163,297,0.98 [0.88-1.08],0.6501888738562186
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17991,125,0.96 [0.83-1.13],0.6460979655242488
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,14213,1638,0.98 [0.94-1.02],0.3306319457255294
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,17772,5197,0.97 [0.95-1.00],0.0281096233979183
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19007,182,1.07 [0.94-1.21],0.3360969381133835
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of liver,19497,636,0.94 [0.88-1.01],0.0906817930491511
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14387,658,0.98 [0.92-1.05],0.5418510179049638
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18040,174,0.90 [0.79-1.03],0.1192583498132478
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19601,359,0.99 [0.90-1.08],0.7526103279826472
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14652,923,0.98 [0.93-1.04],0.5321504431304191
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19251,1065,0.95 [0.90-1.00],0.0575699690498275
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19201,148,0.96 [0.83-1.10],0.5562065099275538
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14353,1778,0.97 [0.93-1.01],0.1954971347792785
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15561,1832,0.97 [0.93-1.01],0.1002864781288362
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18960,99,0.92 [0.77-1.09],0.3359862655208079
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18976,820,1.00 [0.94-1.06],0.8802130504467192
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12941,366,0.96 [0.88-1.05],0.3706961432214084
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19707,22,1.22 [0.83-1.78],0.3091487269823541
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13085,510,0.94 [0.87-1.02],0.1224231098064807
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18324,138,1.00 [0.87-1.16],0.9524697953603286
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19723,43,0.76 [0.59-0.98],0.0314802789979328
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19047,81,0.96 [0.79-1.16],0.689009604689483
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Toxic colitis,18227,71,0.94 [0.76-1.15],0.5427008542489211
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14029,300,1.03 [0.93-1.13],0.6193596740776908
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,18301,145,0.97 [0.84-1.12],0.7238662142545713
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18273,117,0.97 [0.83-1.14],0.7430899967931544
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Umbilical hernia,15150,218,0.96 [0.86-1.08],0.5430788096831326
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12779,204,0.88 [0.78-0.99],0.0377377182936016
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ventral hernia,15162,230,0.99 [0.89-1.11],0.8998101748059439
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Volvulus,12650,75,0.84 [0.69-1.03],0.0905419656216994
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19647,352,1.01 [0.92-1.11],0.8634137193451241
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19428,60,1.00 [0.80-1.25],0.9926791121523076
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17618,142,1.05 [0.91-1.22],0.5070848581588153
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19203,696,0.98 [0.92-1.05],0.5202700392248675
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18628,121,1.02 [0.87-1.20],0.8008035248781281
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17966,490,0.93 [0.86-1.00],0.0532905500142061
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19444,263,1.01 [0.91-1.12],0.8488511365918823
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19641,460,0.97 [0.90-1.05],0.4956399116396083
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19225,44,0.91 [0.71-1.18],0.4981089853196504
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18378,3119,0.97 [0.94-1.00],0.0417664484652567
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19366,362,0.97 [0.89-1.06],0.4976707460013737
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19252,248,1.00 [0.89-1.11],0.9689854818682024
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19409,902,0.97 [0.92-1.03],0.3674050582705683
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19718,49,0.91 [0.71-1.16],0.4530669995854594
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17531,55,0.93 [0.74-1.17],0.5303068653872546
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19058,54,0.85 [0.68-1.08],0.182044766468523
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19432,251,1.01 [0.90-1.12],0.9226871381984264
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17978,502,0.96 [0.89-1.04],0.3569260104483067
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17556,80,0.90 [0.74-1.08],0.2591897662057695
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19663,74,0.80 [0.66-0.98],0.0283021029917444
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18692,185,1.06 [0.94-1.21],0.3394278739294188
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19564,196,0.98 [0.87-1.11],0.7737817735547099
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19256,75,0.94 [0.77-1.15],0.5370104314323224
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17539,63,0.89 [0.72-1.10],0.2810495618542285
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19214,1738,0.97 [0.93-1.01],0.205568244468719
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18015,539,0.95 [0.88-1.03],0.1997229693614553
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17559,83,0.88 [0.73-1.06],0.1781973495563561
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19659,291,0.99 [0.90-1.10],0.9009227922970172
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19244,63,0.98 [0.78-1.22],0.8286013312434088
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19609,241,1.01 [0.90-1.13],0.8899797437342964
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19676,381,1.00 [0.91-1.09],0.9910204307016856
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17581,105,1.02 [0.86-1.21],0.830718337593521
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17758,282,0.93 [0.84-1.03],0.144827000586575
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19664,369,1.00 [0.91-1.09],0.9326309772407276
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17746,270,1.01 [0.91-1.13],0.8203907780578075
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19712,123,0.91 [0.78-1.06],0.2095485240215465
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16479,68,0.98 [0.80-1.21],0.8869254611686951
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17416,5444,1.02 [0.99-1.04],0.1286859648750241
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16216,4244,1.02 [1.00-1.05],0.1057042265481415
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16455,44,1.02 [0.79-1.33],0.8528435682581385
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16451,117,0.99 [0.84-1.16],0.885676916523564
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16491,157,0.98 [0.85-1.12],0.7329802474990876
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19519,52,0.85 [0.67-1.07],0.1638828802013896
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16457,123,0.96 [0.82-1.12],0.5733156796444412
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13231,1259,1.04 [0.99-1.09],0.1297670633067104
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19557,210,1.05 [0.93-1.19],0.391131362436144
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16805,471,1.03 [0.95-1.11],0.4912197566577462
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16001,6802,1.01 [0.99-1.04],0.1881330636480139
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17609,103,0.91 [0.77-1.08],0.3013061820995988
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16563,152,1.00 [0.87-1.15],0.9636859072800588
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16842,431,1.03 [0.95-1.12],0.4262921985831377
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18940,2606,1.00 [0.97-1.03],0.9789862675428164
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16679,268,0.90 [0.81-1.00],0.0478656451237478
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16533,122,1.18 [1.00-1.38],0.0476121046812586
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16512,101,1.10 [0.93-1.32],0.2627804711963726
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19079,84,0.94 [0.78-1.14],0.5279728500040224
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13667,1695,1.01 [0.97-1.06],0.5174455406173539
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12617,645,1.07 [1.00-1.15],0.0488018649719301
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19650,640,1.07 [1.00-1.14],0.0601224829125153
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12034,62,0.96 [0.77-1.19],0.6934707264255238
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12235,263,0.95 [0.85-1.06],0.3380729307713171
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16633,222,0.98 [0.87-1.10],0.6786168428821587
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12380,408,1.03 [0.95-1.13],0.4706862668723968
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16402,68,1.34 [1.08-1.66],0.0085193540025101
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16892,558,1.00 [0.93-1.08],0.9799151896494084
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16587,253,1.02 [0.91-1.14],0.7459821331435454
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12354,382,1.03 [0.94-1.12],0.5464860536217672
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16469,58,1.10 [0.87-1.38],0.4251918680061947
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16459,48,1.16 [0.90-1.50],0.2393760856082585
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17575,69,0.99 [0.80-1.21],0.8945296809712496
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19374,1868,0.96 [0.92-1.00],0.0286553631794153
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18820,1314,0.95 [0.91-1.00],0.0502405959953761
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19593,455,1.06 [0.98-1.15],0.1579893154321519
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14606,2634,1.03 [0.99-1.06],0.1453651147158732
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12009,37,0.91 [0.69-1.21],0.510444903039465
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16496,85,1.17 [0.97-1.42],0.1004984713209243
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12035,63,1.03 [0.83-1.28],0.7903513913968521
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12084,112,1.03 [0.88-1.22],0.6858704514440911
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17711,205,0.88 [0.78-0.99],0.0381000391304967
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17915,409,0.92 [0.84-1.00],0.0413661073938154
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19720,92,1.22 [1.02-1.47],0.0331451431341943
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17971,1637,1.00 [0.96-1.04],0.9953580977477304
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16471,60,1.37 [1.09-1.73],0.0070130457231116
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12100,128,1.03 [0.88-1.20],0.7368522176720125
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16991,657,1.03 [0.96-1.10],0.3986948281054185
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13806,1834,1.01 [0.97-1.06],0.5037756882304025
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19101,106,1.00 [0.84-1.18],0.9679122237752336
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19728,57,1.03 [0.81-1.29],0.8295186444071249
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16479,68,1.02 [0.83-1.26],0.8239769142485827
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17538,1127,1.06 [1.01-1.12],0.0197483981637655
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16499,88,1.00 [0.83-1.20],0.966166433993479
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13724,1752,1.03 [0.98-1.07],0.2197942982006732
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17609,103,0.87 [0.74-1.03],0.117766002215432
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16439,28,0.96 [0.69-1.32],0.7854868012525607
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16499,165,0.93 [0.82-1.07],0.3208900674943902
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16981,570,1.04 [0.97-1.12],0.2845554801239044
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19411,416,1.11 [1.02-1.21],0.0212897290312981
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16875,541,0.98 [0.91-1.05],0.5439135852010992
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19604,450,1.05 [0.97-1.14],0.2449124693194193
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19714,54,1.33 [1.04-1.70],0.0207074066403845
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16548,137,0.96 [0.83-1.11],0.553505221458191
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15388,724,1.02 [0.96-1.09],0.5476043870698037
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16946,535,1.05 [0.97-1.13],0.2477841050599263
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16652,241,0.90 [0.81-1.01],0.0711827309651289
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12037,65,1.11 [0.89-1.38],0.3574956174236439
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14605,2633,1.04 [1.01-1.08],0.0196654551256154
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12669,697,1.01 [0.94-1.08],0.8003361605781
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19301,306,1.09 [0.98-1.20],0.1035775920181696
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19691,63,1.06 [0.85-1.33],0.5906129435925322
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17505,57,1.26 [0.99-1.60],0.0564927342554331
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12030,58,1.02 [0.81-1.29],0.8419809868223963
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16424,90,1.09 [0.91-1.31],0.3671139792629889
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12434,462,1.07 [0.99-1.16],0.1082792627700551
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16696,285,1.04 [0.94-1.16],0.4094613845513529
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16566,232,1.12 [1.00-1.26],0.0485433902279566
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16549,215,0.99 [0.88-1.11],0.8445516331058326
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13926,59,1.23 [0.98-1.55],0.0742602474693392
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19719,59,1.22 [0.97-1.54],0.0868752837754165
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16879,468,1.03 [0.95-1.12],0.4119988387373036
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19085,90,1.17 [0.97-1.41],0.0914735785260123
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18629,2218,1.03 [1.00-1.07],0.0822828681670028
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16536,125,0.98 [0.84-1.14],0.7783121504834085
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16903,569,1.01 [0.94-1.09],0.7805648354192806
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18548,225,0.93 [0.83-1.05],0.2507118999804527
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16532,198,1.03 [0.91-1.17],0.614466128378903
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17973,1639,1.00 [0.95-1.04],0.8278059043019279
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17408,1074,1.01 [0.95-1.06],0.8107887145161695
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16459,48,1.08 [0.84-1.39],0.5531956325592633
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19102,107,0.95 [0.80-1.12],0.5371857054162918
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16554,143,1.08 [0.94-1.25],0.2848741034200539
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16491,80,0.98 [0.81-1.19],0.8246352104236481
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12035,63,1.15 [0.92-1.43],0.2189976204153834
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18609,1783,0.97 [0.93-1.01],0.1501815089485262
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7974,23,1.30 [0.89-1.90],0.1697698381465731
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10112,28,1.34 [0.95-1.89],0.0923413137641561
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19461,262,1.03 [0.92-1.14],0.6476270429449976
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19289,90,0.98 [0.82-1.18],0.8533176914983119
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18546,1720,0.94 [0.90-0.98],0.0021290156822531
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19557,85,0.83 [0.69-1.00],0.0477425247604119
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19508,328,0.97 [0.88-1.07],0.5391909547225926
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cystitis,16576,256,1.01 [0.91-1.13],0.8271630951154338
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Dialysis,16896,70,1.16 [0.94-1.44],0.160100406062558
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8642,1790,1.00 [0.96-1.04],0.9465375555430002
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10192,108,1.12 [0.94-1.33],0.2037960119339914
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,7986,35,1.18 [0.87-1.59],0.2874294190859837
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8434,483,1.04 [0.96-1.13],0.3431013999207359
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16307,5225,0.98 [0.96-1.00],0.0740266884303413
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19536,64,0.96 [0.78-1.20],0.7380768321706765
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,6952,100,0.94 [0.79-1.12],0.4975893738929287
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16850,274,1.02 [0.92-1.13],0.756514180500149
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8373,1521,0.99 [0.95-1.03],0.6447016484588843
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10246,137,1.02 [0.88-1.18],0.8237930645313049
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6953,101,0.94 [0.79-1.11],0.4518584957082343
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16389,69,0.95 [0.77-1.16],0.5918212448352641
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8822,871,0.99 [0.93-1.05],0.6803561996826328
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6905,53,0.80 [0.64-1.01],0.0622937127590609
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7985,34,0.78 [0.59-1.05],0.0978859963228225
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19729,74,1.06 [0.87-1.30],0.5499774799012488
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19722,73,0.88 [0.72-1.07],0.2036571216978876
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18718,2398,0.95 [0.92-0.99],0.0101430699145872
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17117,797,0.93 [0.88-0.99],0.0188079558529301
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10128,44,1.09 [0.84-1.43],0.5041362303869477
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19673,493,1.00 [0.93-1.08],0.9543455753889586
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6973,121,1.05 [0.89-1.23],0.5672785235083413
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6984,132,1.04 [0.89-1.21],0.6117809043371794
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6978,126,1.01 [0.86-1.17],0.9477227634794564
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19704,68,1.07 [0.87-1.32],0.5264463763466416
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18189,1869,0.97 [0.93-1.01],0.14400496534497
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10181,72,0.96 [0.79-1.19],0.7342307358071356
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8015,64,1.17 [0.93-1.46],0.1730428848824806
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8082,131,0.97 [0.84-1.13],0.7191057008920114
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8000,49,0.83 [0.65-1.06],0.1415865014927076
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8038,87,0.94 [0.78-1.13],0.5031091214857899
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16900,324,1.02 [0.92-1.12],0.7592982485524604
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19340,160,1.06 [0.92-1.21],0.4212774600997852
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8053,102,0.94 [0.79-1.11],0.451978683502323
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7973,22,0.79 [0.55-1.14],0.2040173252063428
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8132,181,0.95 [0.84-1.08],0.4566483871413649
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8033,82,1.12 [0.92-1.35],0.2723750740735651
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8133,182,0.93 [0.82-1.06],0.2811448472600209
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19517,45,0.85 [0.66-1.09],0.2069225254874662
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6978,126,0.97 [0.83-1.13],0.723749411681355
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19524,2948,0.97 [0.94-1.00],0.0362295374468893
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16651,75,0.99 [0.81-1.21],0.9461697087669402
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16967,141,1.00 [0.86-1.16],0.9894613307910876
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19231,32,1.02 [0.75-1.39],0.904568323770896
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16544,224,0.97 [0.86-1.08],0.5476960953987728
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19537,338,1.02 [0.93-1.12],0.6538668873011956
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7985,34,1.00 [0.74-1.35],0.9844850848518324
